|
JANUARY 31, 2022 |
2022 Semi-Annual Report (Unaudited) |
iShares Trust
· |
iShares Cloud 5G and Tech ETF | IDAT | NYSE Arca |
· |
iShares Cybersecurity and Tech ETF | IHAK | NYSE Arca |
· |
iShares Exponential Technologies ETF | XT | NASDAQ |
· |
iShares Genomics Immunology and Healthcare ETF | IDNA | NYSE Arca |
· |
iShares Robotics and Artificial Intelligence Multisector ETF | IRBO | NYSE Arca |
· |
iShares Self-Driving EV and Tech ETF | IDRV | NYSE Arca |
· |
iShares U.S. Tech Breakthrough Multisector ETF | TECB | NYSE Arca |
· |
iShares Virtual Work and Life Multisector ETF | IWFH | NYSE Arca |
Dear Shareholder,
The 12-month reporting period as of January 31, 2022 saw a continuation of the resurgent growth that followed the initial coronavirus (or “COVID-19”) pandemic reopening, albeit at a slower pace. The global economy weathered the emergence of several variant strains and the resulting peaks and troughs in infections amid optimism that increasing vaccinations and economic adaptation could help contain the pandemic’s disruptions. Continued growth meant that the U.S. economy regained and then surpassed its pre-pandemic output. However, rapid changes in consumer spending led to supply constraints and elevated inflation.
Equity prices were mixed, as persistently high inflation drove investors’ expectations for higher interest rates, which particularly weighed on relatively high valuation growth stocks and economically sensitive small-capitalization stocks. Overall, small-capitalization U.S. stocks declined slightly, while large-capitalization U.S. stocks posted a strong advance. International equities from developed markets also gained, although emerging market stocks declined, pressured by rising interest rates and a strengthening U.S. dollar.
The 10-year U.S. Treasury yield (which is inversely related to bond prices) rose significantly during the reporting period as the economy expanded rapidly and inflation reached its highest annualized reading in decades. In the corporate bond market, the improving economy assuaged credit concerns and led to positive returns for high-yield corporate bonds, outpacing the modest negative return of investment-grade corporate bonds.
The U.S. Federal Reserve (the “Fed”) maintained accommodative monetary policy during the reporting period by keeping near-zero interest rates. However, the Fed’s tone shifted late in the period, as it reduced its bond-buying program and raised the prospect of higher rates in 2022. Continued high inflation and the Fed’s new tone led many analysts to anticipate that the Fed will raise interest rates multiple times throughout the year.
Looking ahead, however, the horrific war in Ukraine has significantly clouded the outlook for the global economy. Sanctions on Russia and general wartime disruption are likely to drive already-high commodity prices even further upwards, and we have already seen spikes in energy and metal markets. While this will exacerbate inflationary pressure, it could also constrain economic growth, making the Fed’s way forward less clear. Its challenge will be combating inflation without stifling a recovery that is now facing additional supply shocks.
In this environment, we favor an overweight to equities, as we believe low interest rates and continued economic growth will support further gains, albeit likely more modest than what we saw in 2021. Sectors that are better poised to manage the transition to a lower-carbon world, such as technology and health care, are particularly attractive in the long term. U.S. and other developed-market equities have room for further growth, while we believe Chinese equities stand to gain from a more accommodative monetary and fiscal environment. We are underweight long-term credit, but inflation-protected U.S. Treasuries, Asian fixed income, and emerging market local-currency bonds offer potential opportunities. We believe that international diversification and a focus on sustainability can help provide portfolio resilience, and the disruption created by the coronavirus appears to be accelerating the shift toward sustainable investments.
In this environment, our view is that investors need to think globally, extend their scope across a broad array of asset classes, and be nimble as market conditions change. We encourage you to talk with your financial advisor and visit iShares.com for further insight about investing in today’s markets.
Sincerely,
Rob Kapito
President, BlackRock, Inc.
Rob Kapito
President, BlackRock, Inc.
Total Returns as of January 31, 2022
| ||||||
6-Month | 12-Month | |||||
U.S.
large cap equities
|
3.44 | % | 23.29% | |||
U.S.
small cap equities
|
(8.41 | ) | (1.21) | |||
International
equities
|
(3.43 | ) | 7.03 | |||
Emerging
market equities
|
(4.59 | ) | (7.23) | |||
3-month
Treasury bills
|
0.01 | 0.04 | ||||
U.S.
Treasury securities
|
(3.87 | ) | (4.43) | |||
U.S.
investment grade bonds
|
(3.17 | ) | (2.97) | |||
Tax-exempt
municipal bonds
|
(2.56 | ) | (1.22) | |||
U.S. high yield bonds (Bloomberg U.S. Corporate High Yield 2% Issuer Capped Index)
|
(1.55 | ) | 2.05 | |||
Past performance is not an indication of future results. Index performance is shown for illustrative purposes only. You cannot invest directly in an index.
|
2 |
T H I S P A G E I S N O T P A R T O F Y O U R F U N D R E P O R T |
Page | ||||
|
||||
2 | ||||
4 | ||||
12 | ||||
12 | ||||
13 | ||||
Financial Statements: |
||||
39 | ||||
41 | ||||
43 | ||||
47 | ||||
55 | ||||
65 | ||||
66 | ||||
67 | ||||
68 |
3 |
Fund Summary as of January 31, 2022 | iShares® Cloud 5G and Tech ETF |
Investment Objective
The iShares Cloud 5G and Tech ETF (the “Fund”) seeks to track the investment results of an index composed of companies from developed and emerging markets that could benefit from providing products, services, and technologies related to cloud computing and 5G, as represented by the Morningstar® Global Digital Infrastructure & Connectivity Index (the “Index”). The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index.
Performance
Cumulative Total Returns | ||||||||
6 Months |
Since Inception |
|||||||
Fund NAV |
6.01 | % | 10.62 | % | ||||
Fund Market |
5.97 | 10.58 | ||||||
Index |
5.31 | 9.75 |
The inception date of the Fund was 6/8/21. The first day of secondary market trading was 6/10/21.
Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 12 for more information.
Expense Example
Actual | Hypothetical 5% Return | |||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||
|
Beginning Account Value |
|
|
Ending Account Value (01/31/22) |
|
|
Expenses Paid During the Period |
(a) |
|
Beginning Account Value (08/01/21) |
|
|
Ending Account Value |
|
|
Expenses Paid During the Period |
(a) |
|
Annualized Expense Ratio |
| ||||||||||
$ | 1,000.00 | $ | 1,060.10 | $ | 2.44 | $ | 1,000.00 | $ | 1,022.80 | $ | 2.40 | 0.47 | % |
(a) |
Expenses are calculated using the Fund’s annualized expense ratio (as disclosed in the table), multiplied by the average account value for the period, multiplied by the number of days in the period (184 days) and divided by the number of days in the year (365 days). Other fees, such as brokerage commissions and other fees to financial intermediaries, may be paid which are not reflected in the tables and examples above. See “Shareholder Expenses” on page 12 for more information. |
Portfolio Information
ALLOCATION BY SECTOR
Sector |
|
Percent of Total Investments |
(a) | |
Semiconductors & Semiconductor Equipment |
37.9 | % | ||
Software |
19.7 | |||
Communications Equipment |
17.1 | |||
Electronic Equipment, Instruments & Components |
7.4 | |||
Equity Real Estate Investment Trusts (REITs) |
3.5 | |||
Technology Hardware, Storage & Peripherals |
3.4 | |||
Chemicals |
2.6 | |||
Media |
2.6 | |||
Construction & Engineering |
2.4 | |||
IT Services |
2.1 | |||
Diversified Telecommunication Services |
1.3 |
GEOGRAPHIC ALLOCATION
Country/Geographic Region |
|
Percent of Total Investments |
(a) | |
United States |
64.9 | % | ||
Taiwan |
10.8 | |||
Japan |
7.0 | |||
Netherlands |
5.1 | |||
Sweden |
3.3 | |||
Finland |
2.8 | |||
Germany |
2.4 | |||
United Kingdom |
1.2 | |||
Other (each representing less than 1%) |
2.5 |
(a) |
Excludes money market funds. |
4 |
2 0 2 2 I S H A R E S S E M I - A N N U A L R E P O R T T O S H A R E H O L D E R S |
Fund Summary as of January 31, 2022 | iShares® Cybersecurity and Tech ETF |
Investment Objective
The iShares Cybersecurity and Tech ETF (the “Fund”) seeks to track the investment results of an index composed of developed and emerging market companies that are involved in cyber security and technology, including cyber security hardware, software, products, and services, as represented by the NYSE® FactSet® Global Cyber Security Index (the “Index”). The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index.
Performance
Average Annual Total Returns | Cumulative Total Returns | |||||||||||||||||||||||
6 Months | 1 Year | Since Inception |
1 Year | Since Inception |
||||||||||||||||||||
Fund NAV |
(7.43 | )% | (0.88 | )% | 20.71 | % | (0.88 | )% | 64.50 | % | ||||||||||||||
Fund Market |
(7.47 | ) | (0.98 | ) | 20.76 | (0.98 | ) | 64.66 | ||||||||||||||||
Index |
(7.68 | ) | (0.84 | ) | 21.09 | (0.84 | ) | 65.61 |
The inception date of the Fund was 6/11/19. The first day of secondary market trading was 6/13/19.
Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 12 for more information.
Expense Example
Actual | Hypothetical 5% Return | |||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||
|
Beginning Account Value |
|
|
Ending Account Value (01/31/22) |
|
|
Expenses Paid During the Period |
(a) |
|
Beginning Account Value (08/01/21) |
|
|
Ending Account Value |
|
|
Expenses Paid During the Period |
(a) |
|
Annualized Expense Ratio |
| ||||||||||
$ 1,000.00 | $ 925.70 | $ 2.28 | $ 1,000.00 | $ 1,022.80 | $ 2.40 | 0.47 | % |
(a) |
Expenses are calculated using the Fund’s annualized expense ratio (as disclosed in the table), multiplied by the average account value for the period, multiplied by the number of days in the period (184 days) and divided by the number of days in the year (365 days). Other fees, such as brokerage commissions and other fees to financial intermediaries, may be paid which are not reflected in the tables and examples above. See “Shareholder Expenses” on page 12 for more information. |
Portfolio Information
ALLOCATION BY SECTOR
Sector |
|
Percent of Total Investments |
(a) | |
Software |
71.6 | % | ||
Professional Services |
9.7 | |||
Communications Equipment |
9.7 | |||
IT Services |
9.0 |
GEOGRAPHIC ALLOCATION
Country/Geographic Region |
|
Percent of Total Investments |
(a) | |
United States |
76.8 | % | ||
Israel |
8.6 | |||
Japan |
3.9 | |||
Taiwan |
2.4 | |||
Canada |
2.4 | |||
United Kingdom |
2.2 | |||
Denmark |
1.6 | |||
Germany |
1.4 | |||
Other (each representing less than 1%) |
0.7 |
(a) |
Excludes money market funds. |
F U N D S U M M A R Y |
5 |
Fund Summary as of January 31, 2022 | iShares® Exponential Technologies ETF |
Investment Objective
The iShares Exponential Technologies ETF (the “Fund”) seeks to track the investment results of an index composed of stocks of developed and emerging market companies that create or use exponential technologies, as represented by the Morningstar Exponential Technologies IndexSM (the “Index”). The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index.
Performance
Average Annual Total Returns | Cumulative Total Returns | |||||||||||||||||||||||||||||||
6 Months | 1 Year | 5 Years |
Since Inception |
1 Year | 5 Years | Since Inception |
||||||||||||||||||||||||||
Fund NAV |
(6.51 | )% | 2.87 | % | 17.72 | % | 14.55 | % | 2.87 | % | 126.04 | % | 154.34 | % | ||||||||||||||||||
Fund Market |
(6.68 | ) | 2.84 | 17.66 | 14.53 | 2.84 | 125.46 | 154.14 | ||||||||||||||||||||||||
Index |
(6.93 | ) | 2.56 | 17.94 | 14.74 | 2.56 | 128.18 | 157.01 |
The inception date of the Fund was 3/19/15. The first day of secondary market trading was 3/23/15.
Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 12 for more information.
Expense Example
Actual | Hypothetical 5% Return | |||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||
|
Beginning Account Value (08/01/21) |
|
|
Ending Account Value (01/31/22) |
|
|
Expenses Paid During the Period |
(a) |
|
Beginning Account Value (08/01/21) |
|
|
Ending Account Value (01/31/22) |
|
|
Expenses Paid During the Period |
(a) |
|
Annualized Expense Ratio |
| ||||||||||
$ 1,000.00 | $ 934.90 | $ 2.19 | $ 1,000.00 | $ 1,022.90 | $ 2.29 | 0.45 | % |
(a) |
Expenses are calculated using the Fund’s annualized expense ratio (as disclosed in the table), multiplied by the average account value for the period, multiplied by the number of days in the period (184 days) and divided by the number of days in the year (365 days). Other fees, such as brokerage commissions and other fees to financial intermediaries, may be paid which are not reflected in the tables and examples above. See “Shareholder Expenses” on page 12 for more information. |
Portfolio Information
ALLOCATION BY SECTOR
Sector |
|
Percent of Total Investments |
(a) | |
Information Technology |
53.2 | % | ||
Health Care |
22.7 | |||
Industrials |
6.3 | |||
Consumer Discretionary |
4.6 | |||
Communication Services |
4.3 | |||
Financials |
2.7 | |||
Materials |
2.6 | |||
Utilities |
2.0 | |||
Other (each representing less than 1%) |
1.6 |
TEN LARGEST GEOGRAPHIC ALLOCATION
Country/Geographic Region |
|
Percent of Total Investments |
(a) | |
United States |
59.7 | % | ||
Japan |
7.1 | |||
China |
5.7 | |||
United Kingdom |
3.6 | |||
Netherlands |
3.4 | |||
Australia |
3.3 | |||
Taiwan |
2.2 | |||
Switzerland |
2.1 | |||
Canada |
1.9 | |||
India |
1.6 |
(a) |
Excludes money market funds. |
6 |
2 0 2 2 I S H A R E S S E M I - A N N U A L R E P O R T T O S H A R E H O L D E R S |
Fund Summary as of January 31, 2022 |
iShares® Genomics Immunology and Healthcare ETF |
Investment Objective
The iShares Genomics Immunology and Healthcare ETF (the “Fund”) seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering, as represented by the NYSE® FactSet Global Genomics and Immuno Biopharma IndexTM (the “Index”). The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index.
Performance
Average Annual Total Returns | Cumulative Total Returns | |||||||||||||||||||||||
6 Months | 1 Year | Since Inception |
1 Year | Since Inception |
||||||||||||||||||||
Fund NAV |
(26.91 | )% | (27.20 | )% | 16.98 | % | (27.20 | )% | 51.37 | % | ||||||||||||||
Fund Market |
(27.12 | ) | (27.39 | ) | 16.90 | (27.39 | ) | 51.11 | ||||||||||||||||
Index |
(27.06 | ) | (27.41 | ) | 16.82 | (27.41 | ) | 50.66 |
The inception date of the Fund was 6/11/19. The first day of secondary market trading was 6/13/19.
Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 12 for more information.
Expense Example
Actual |
Hypothetical 5% Return |
|||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||
|
Beginning Account Value (08/01/21) |
|
|
Ending Account Value (01/31/22) |
|
|
Expenses Paid During the Period |
(a) |
|
Beginning Account Value (08/01/21) |
|
|
Ending Account Value (01/31/22) |
|
|
Expenses Paid During the Period |
(a) |
|
Annualized Expense Ratio |
| ||||||||||
$ 1,000.00 | $ | 730.90 | $ | 2.05 | $ | $1,000.00 | $ | 1,022.80 | $ | 2.40 | 0.47 | % |
(a) |
Expenses are calculated using the Fund’s annualized expense ratio (as disclosed in the table), multiplied by the average account value for the period, multiplied by the number of days in the period (184 days) and divided by the number of days in the year (365 days). Other fees, such as brokerage commissions and other fees to financial intermediaries, may be paid which are not reflected in the tables and examples above. See “Shareholder Expenses” on page 12 for more information. |
Portfolio Information
ALLOCATION BY SECTOR
Sector |
|
Percent of Total Investments |
(a) | |
Biotechnology |
71.9 | % | ||
Pharmaceuticals |
20.5 | |||
Life Sciences Tools & Services |
7.6 |
GEOGRAPHIC ALLOCATION
Country/Geographic Region |
|
Percent of Total Investments |
(a) | |
United States |
61.3 | % | ||
Japan |
10.2 | |||
Germany |
6.6 | |||
France |
6.5 | |||
Switzerland |
4.7 | |||
Denmark |
4.4 | |||
China |
3.2 | |||
Taiwan |
1.7 | |||
Netherlands |
1.0 | |||
United Kingdom |
0.4 |
(a) |
Excludes money market funds. |
F U N D S U M M A R Y |
7 |
Fund Summary as of January 31, 2022 |
iShares® Robotics and Artificial Intelligence Multisector ETF |
Investment Objective
The iShares Robotics and Artificial Intelligence Multisector ETF (the “Fund”) seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in robotics technologies and artificial intelligence, as represented by the NYSE® FactSet® Global Robotics and Artificial Intelligence Index (the “Index”). The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index.
Performance
Average Annual Total Returns | Cumulative Total Returns | |||||||||||||||||||||||
6 Months | 1 Year | Since Inception |
1 Year | Since Inception |
||||||||||||||||||||
Fund NAV |
(13.08 | )% | (13.35 | )% | 14.17 | % | (13.35 | )% | 61.21 | % | ||||||||||||||
Fund Market |
(13.42 | ) | (13.98 | ) | 14.06 | (13.98 | ) | 60.66 | ||||||||||||||||
Index |
(13.34 | ) | (13.69 | ) | 14.37 | (13.69 | ) | 62.02 |
The inception date of the Fund was 6/26/18. The first day of secondary market trading was 6/28/18.
Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 12 for more information.
Expense Example
Actual |
Hypothetical 5% Return |
|||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||
|
Beginning Account Value (08/01/21) |
|
|
Ending Account Value (01/31/22) |
|
|
Expenses Paid During the Period |
(a) |
|
Beginning Account Value (08/01/21) |
|
|
Ending Account Value (01/31/22) |
|
|
Expenses Paid During the Period |
(a) |
|
Annualized Expense Ratio |
| ||||||||||
$ 1,000.00 | $ | 869.20 | $ | 2.21 | $ | 1,000.00 | $ | 1,022.80 | $ | 2.40 | 0.47 | % |
(a) |
Expenses are calculated using the Fund’s annualized expense ratio (as disclosed in the table), multiplied by the average account value for the period, multiplied by the number of days in the period (184 days) and divided by the number of days in the year (365 days). Other fees, such as brokerage commissions and other fees to financial intermediaries, may be paid which are not reflected in the tables and examples above. See “Shareholder Expenses” on page 12 for more information. |
Portfolio Information
ALLOCATION BY SECTOR
Sector |
|
Percent of Total Investments |
(a) | |
Information Technology |
53.9 | % | ||
Communication Services |
20.8 | |||
Industrials |
14.9 | |||
Consumer Discretionary |
7.4 | |||
Health Care |
3.0 |
TEN LARGEST GEOGRAPHIC ALLOCATION
Country/Geographic Region |
|
Percent of Total Investments |
(a) | |
United States |
49.8 | % | ||
China |
13.5 | |||
Japan |
10.8 | |||
Taiwan |
7.8 | |||
South Korea |
3.5 | |||
France |
3.0 | |||
Israel |
2.6 | |||
Netherlands |
2.2 | |||
Germany |
1.8 | |||
United Kingdom |
1.6 |
(a) |
Excludes money market funds. |
8 |
2 0 2 2 I S H A R E S S E M I - A N N U A L R E P O R T T O S H A R E H O L D E R S |
Fund Summary as of January 31, 2022 |
iShares® Self-Driving EV and Tech ETF |
Investment Objective
The iShares Self-Driving EV and Tech ETF (the “Fund”) seeks to track the investment results of an index composed of developed and emerging market companies that may benefit from growth and innovation in and around electric vehicles, battery technologies and autonomous driving technologies, as represented by the NYSE® FactSet Global Autonomous Driving and Electric Vehicle Index (the “Index”). The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index.
Performance
Average Annual Total Returns | Cumulative Total Returns | |||||||||||||||||||||||
6 Months | 1 Year |
Since Inception |
1 Year | Since Inception |
||||||||||||||||||||
Fund NAV |
0.95 | % | 13.79 | % | 29.04 | % | 13.79 | % | 104.06 | % | ||||||||||||||
Fund Market |
0.85 | 13.50 | 29.01 | 13.50 | 103.91 | |||||||||||||||||||
Index |
0.43 | 13.25 | 28.97 | 13.25 | 103.29 |
The inception date of the Fund was 4/16/19. The first day of secondary market trading was 4/18/19.
Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 12 for more information.
Expense Example
Actual |
Hypothetical 5% Return |
|||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||
|
Beginning Account Value (08/01/21) |
|
|
Ending Account Value (01/31/22) |
|
|
Expenses Paid During the Period |
(a) |
|
Beginning Account Value (08/01/21) |
|
|
Ending Account Value (01/31/22) |
|
|
Expenses Paid During the Period |
(a) |
|
Annualized Expense Ratio |
| ||||||||||
$ 1,000.00 | $ | 1,009.50 | $ | 2.38 | $ | 1,000.00 | $ | 1,022.80 | $ | 2.40 | 0.47 | % |
(a) |
Expenses are calculated using the Fund’s annualized expense ratio (as disclosed in the table), multiplied by the average account value for the period, multiplied by the number of days in the period (184 days) and divided by the number of days in the year (365 days). Other fees, such as brokerage commissions and other fees to financial intermediaries, may be paid which are not reflected in the tables and examples above. See “Shareholder Expenses” on page 12 for more information. |
Portfolio Information
ALLOCATION BY SECTOR
Sector |
|
Percent of Total Investments |
(a) | |
Consumer Discretionary |
45.1 | % | ||
Information Technology |
37.7 | |||
Industrials |
8.3 | |||
Communication Services |
4.8 | |||
Materials |
4.1 |
TEN LARGEST GEOGRAPHIC ALLOCATION
Country/Geographic Region |
|
Percent of Total Investments |
(a) | |
United States |
48.0 | % | ||
Germany |
11.0 | |||
Japan |
10.7 | |||
South Korea |
7.6 | |||
Netherlands |
4.8 | |||
China |
4.8 | |||
Switzerland |
3.0 | |||
Sweden |
2.9 | |||
United Kingdom |
2.3 | |||
Taiwan |
1.3 |
(a) |
Excludes money market funds. |
F U N D S U M M A R Y |
9 |
Fund Summary as of January 31, 2022 |
iShares® U.S. Tech Breakthrough Multisector ETF |
Investment Objective
The iShares U.S. Tech Breakthrough Multisector ETF (the “Fund”) seeks to track the investment results of an index composed of U.S. companies that could benefit from various breakthrough technologies, including robotics and artificial intelligence, cloud and data tech, cybersecurity, genomics and immunology, and financial technology, as represented by the NYSE® FactSet® U.S. Tech Breakthrough IndexTM (the “Index”). The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index.
Performance
Average Annual Total Returns | Cumulative Total Returns | |||||||||||||||||||||||
6 Months | 1 Year | Since Inception |
1 Year | Since Inception |
||||||||||||||||||||
Fund NAV |
(8.57 | )% | 6.86 | % | 22.15 | % | 6.86 | % | 51.18 | % | ||||||||||||||
Fund Market |
(8.66 | ) | 6.78 | 22.10 | 6.78 | 51.06 | ||||||||||||||||||
Index |
(8.42 | ) | 7.22 | 22.60 | 7.22 | 52.22 |
The inception date of the Fund was 1/8/20. The first day of secondary market trading was 1/10/20.
Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 12 for more information.
Expense Example
Actual | Hypothetical 5% Return | |||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||
|
Beginning Account Value (08/01/21) |
|
|
Ending Account Value (01/31/22) |
|
|
Expenses Paid During the Period |
(a) |
|
Beginning Account Value (08/01/21) |
|
|
Ending Account Value (01/31/22) |
|
|
Expenses Paid During the Period |
(a) |
|
Annualized Expense Ratio |
| ||||||||||
$ 1,000.00 | $ 914.30 | $ 1.45 | $ 1,000.00 | $ 1,023.70 | $ 1.53 | 0.30 | % |
(a) |
Expenses are calculated using the Fund’s annualized expense ratio (as disclosed in the table), multiplied by the average account value for the period, multiplied by the number of days in the period (184 days) and divided by the number of days in the year (365 days). Other fees, such as brokerage commissions and other fees to financial intermediaries, may be paid which are not reflected in the tables and examples above. See “Shareholder Expenses” on page 12 for more information. |
Portfolio Information
ALLOCATION BY SECTOR
Sector |
|
Percent of Total Investments |
(a) | |
Information Technology |
65.0 | % | ||
Communication Services |
15.0 | |||
Health Care |
9.9 | |||
Consumer Discretionary |
6.2 | |||
Real Estate |
2.2 | |||
Industrials |
1.1 | |||
Financials |
0.6 |
TEN LARGEST HOLDINGS
Security |
|
Percent of Total Investments |
(a) | |
Apple Inc. |
4.7 | % | ||
Meta Platforms Inc, Class A |
4.4 | |||
Microsoft Corp. |
4.2 | |||
Alphabet Inc., Class A |
4.1 | |||
salesforce.com Inc. |
3.9 | |||
Amazon.com Inc. |
3.8 | |||
NVIDIA Corp. |
3.5 | |||
Walt Disney Co. (The) |
3.1 | |||
Adobe Inc. |
3.0 | |||
Gilead Sciences Inc. |
2.8 |
(a) |
Excludes money market funds. |
10 |
2 0 2 2 I S H A R E S S E M I - A N N U A L R E P O R T T O S H A R E H O L D E R S |
Fund Summary as of January 31, 2022 | iShares® Virtual Work and Life Multisector ETF |
Investment Objective
The iShares Virtual Work and Life Multisector ETF (the “Fund”) seeks to track the investment results of an index composed of U.S. and non-U.S. companies that provide products, services and technologies that empower individuals to work remotely, and support an increasingly virtual way of life across entertainment, wellness and learning, as represented by the NYSE® FactSet® Global Virtual Work and Life Index (the “Index”). The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index.
Performance
Average Annual Total Returns | Cumulative Total Returns | |||||||||||||||||||||||
6 Months | 1 Year | Since Inception |
1 Year | Since Inception |
||||||||||||||||||||
Fund NAV |
(29.09 | )% | (35.93 | )% | (15.72 | )% | (35.93 | )% | (20.51 | )% | ||||||||||||||
Fund Market |
(28.80 | ) | (35.90 | ) | (15.53 | ) | (35.90 | ) | (20.27 | ) | ||||||||||||||
Index |
(29.37 | ) | (36.15 | ) | (15.85 | ) | (36.15 | ) | (20.59 | ) |
The inception date of the Fund was 9/29/20. The first day of secondary market trading was 10/1/20.
Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 12 for more information.
Expense Example
Actual |
Hypothetical 5% Return |
|||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||
|
Beginning Account Value (08/01/21) |
|
|
Ending Account Value (01/31/22) |
|
|
Expenses Paid During the Period |
(a) |
|
Beginning Account Value (08/01/21) |
|
|
Ending Account Value (01/31/22) |
|
|
Expenses Paid During the Period |
(a) |
|
Annualized Expense Ratio |
| ||||||||||
$ 1,000.00 | $ 709.10 | $ 2.02 | $ 1,000.00 | $ 1,022.80 | $ 2.40 | 0.47 | % |
(a) |
Expenses are calculated using the Fund’s annualized expense ratio (as disclosed in the table), multiplied by the average account value for the period, multiplied by the number of days in the period (184 days) and divided by the number of days in the year (365 days). Other fees, such as brokerage commissions and other fees to financial intermediaries, may be paid which are not reflected in the tables and examples above. See “Shareholder Expenses” on page 12 for more information. |
Portfolio Information
ALLOCATION BY SECTOR
Sector |
|
Percent of Total Investments |
(a) | |
Information Technology |
39.5 | % | ||
Communication Services |
36.1 | |||
Consumer Discretionary |
17.3 | |||
Health Care |
5.8 | |||
Consumer Staples |
1.3 |
TEN LARGEST HOLDINGS
Security |
|
Percent of Total Investments |
(a) | |
Activision Blizzard Inc. |
3.0 | % | ||
Citrix Systems Inc. |
2.8 | |||
Nintendo Co. Ltd. |
2.5 | |||
GN Store Nord A/S |
2.4 | |||
Kuaishou Technology |
2.4 | |||
Electronic Arts Inc. |
2.3 | |||
Tencent Holdings Ltd. |
2.3 | |||
Anaplan Inc. |
2.3 | |||
Dropbox Inc., Class A |
2.3 | |||
Zendesk Inc. |
2.2 |
(a) |
Excludes money market funds. |
F U N D S U M M A R Y |
11 |
Past performance is not an indication of future results. Financial markets have experienced extreme volatility and trading in many instruments has been disrupted. These circumstances may continue for an extended period of time and may continue to affect adversely the value and liquidity of each Fund’s investments. As a result, current performance may be lower or higher than the performance data quoted. Performance data current to the most recent month-end is available at iShares.com. Performance results assume reinvestment of all dividends and capital gain distributions and do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. The investment return and principal value of shares will vary with changes in market conditions. Shares may be worth more or less than their original cost when they are redeemed or sold in the market. Performance for certain funds may reflect a waiver of a portion of investment advisory fees. Without such a waiver, performance would have been lower.
Net asset value or “NAV” is the value of one share of a fund as calculated in accordance with the standard formula for valuing mutual fund shares. Beginning August 10, 2020, the price used to calculate market return (“Market Price”) is the closing price. Prior to August 10, 2020, Market Price was determined by using the midpoint between the highest bid and the lowest ask on the primary stock exchange on which shares of a fund are listed for trading, as of the time that such fund’s NAV is calculated. Since shares of a fund may not trade in the secondary market until after the fund’s inception, for the period from inception to the first day of secondary market trading in shares of the fund, the NAV of the fund is used as a proxy for the Market Price to calculate market returns. Market and NAV returns assume that dividends and capital gain distributions have been reinvested at Market Price and NAV, respectively.
An index is a statistical composite that tracks a specified financial market or sector. Unlike a fund, an index does not actually hold a portfolio of securities and therefore does not incur the expenses incurred by a fund. These expenses negatively impact fund performance. Also, market returns do not include brokerage commissions that may be payable on secondary market transactions. If brokerage commissions were included, market returns would be lower.
Shareholders of each Fund may incur the following charges: (1) transactional expenses, including brokerage commissions on purchases and sales of fund shares and (2) ongoing expenses, including management fees and other fund expenses. The expense examples shown (which are based on a hypothetical investment of $1,000 invested at the beginning of the period (or from the commencement of operations if less than 6 months) and held through the end of the period) are intended to assist shareholders both in calculating expenses based on an investment in each Fund and in comparing these expenses with similar costs of investing in other funds.
The expense examples provide information about actual account values and actual expenses. Annualized expense ratios reflect contractual and voluntary fee waivers, if any. In order to estimate the expenses a shareholder paid during the period covered by this report, shareholders can divide their account value by $1,000 and then multiply the result by the number under the heading entitled “Expenses Paid During Period.”
The expense examples also provide information about hypothetical account values and hypothetical expenses based on a Fund’s actual expense ratio and an assumed rate of return of 5% per year before expenses. In order to assist shareholders in comparing the ongoing expenses of investing in a Funds and other funds, compare the 5% hypothetical examples with the 5% hypothetical examples that appear in the shareholder reports of the other funds.
The expenses shown in the expense examples are intended to highlight shareholders’ ongoing costs only and do not reflect any transactional expenses, such as brokerage commissions and other fees paid on purchases and sales of fund shares. Therefore, the hypothetical examples are useful in comparing ongoing expenses only and will not help shareholders determine the relative total expenses of owning different funds. If these transactional expenses were included, shareholder expenses would have been higher.
12 |
2 0 2 2 I S H A R E S S E M I - A N N U A L R E P O R T T O S H A R E H O L D E R S |
Schedule of Investments (unaudited) January 31, 2022 |
iShares® Cloud 5G and Tech ETF (Percentages shown are based on Net Assets) |
Security | Shares | Value | ||||||
Common Stocks |
||||||||
Chemicals — 2.6% | ||||||||
DuPont de Nemours Inc. |
3,052 | $ | 233,783 | |||||
|
|
|||||||
Communications Equipment — 17.0% | ||||||||
Arista Networks Inc.(a) |
1,920 | 238,675 | ||||||
Ciena Corp.(a) |
3,872 | 256,752 | ||||||
F5 Inc.(a) |
1,048 | 217,586 | ||||||
Juniper Networks Inc. |
7,376 | 256,832 | ||||||
Nokia OYJ(a) |
40,808 | 243,364 | ||||||
Telefonaktiebolaget LM Ericsson, Class B |
23,220 | 289,927 | ||||||
|
|
|||||||
1,503,136 | ||||||||
Construction & Engineering — 2.5% | ||||||||
China Communications Services Corp. Ltd., Class H |
72,000 | 38,326 | ||||||
COMSYS Holdings Corp. |
4,400 | 104,694 | ||||||
EXEO Group Inc. |
3,600 | 73,166 | ||||||
|
|
|||||||
216,186 | ||||||||
Diversified Telecommunication Services — 1.3% | ||||||||
Cogent Communications Holdings Inc. |
1,344 | 85,492 | ||||||
NOS SGPS SA |
6,632 | 26,107 | ||||||
|
|
|||||||
111,599 | ||||||||
Electronic
Equipment, Instruments & |
||||||||
Murata Manufacturing Co. Ltd. |
3,200 | 240,586 | ||||||
Quectel Wireless Solutions Co. Ltd., Class A |
400 | 11,938 | ||||||
Taiyo Yuden Co. Ltd. |
4,000 | 194,285 | ||||||
Yageo Corp. |
12,000 | 204,513 | ||||||
|
|
|||||||
651,322 | ||||||||
Equity
Real Estate Investment Trusts |
||||||||
CyrusOne Inc. |
2,688 | 241,517 | ||||||
Keppel DC REIT |
40,800 | 64,766 | ||||||
|
|
|||||||
306,283 | ||||||||
IT Services — 2.1% | ||||||||
Computacenter PLC |
3,040 | 109,468 | ||||||
Kingsoft Cloud Holdings Ltd., ADR(a)(b) |
3,260 | 27,547 | ||||||
Megaport Ltd.(a) |
5,012 | 48,214 | ||||||
|
|
|||||||
185,229 | ||||||||
Media — 2.6% | ||||||||
DISH Network Corp., Class A(a) |
7,420 | 232,988 | ||||||
|
|
|||||||
Semiconductors &
Semiconductor |
||||||||
Analog Devices Inc. |
1,292 | 211,850 | ||||||
Broadcom Inc. |
412 | 241,383 | ||||||
Infineon Technologies AG |
5,180 | 215,114 | ||||||
Intel Corp. |
4,648 | 226,915 | ||||||
MACOM Technology Solutions Holdings Inc., Class H(a) |
1,464 | 89,611 | ||||||
MediaTek Inc. |
6,000 | 238,315 | ||||||
Microchip Technology Inc. |
2,760 | 213,845 | ||||||
NXP Semiconductors NV |
1,056 | 216,945 |
Security | Shares | Value | ||||||
Semiconductors
& Semiconductor |
||||||||
Qorvo Inc.(a) |
1,492 | $ | 204,822 | |||||
QUALCOMM Inc. |
1,320 | 232,003 | ||||||
Skyworks Solutions Inc. |
1,504 | 220,366 | ||||||
STMicroelectronics NV |
4,924 | 231,530 | ||||||
Taiwan Semiconductor Manufacturing Co. Ltd. |
11,000 | 254,342 | ||||||
Win Semiconductors Corp. |
12,000 | 148,659 | ||||||
Wolfspeed Inc.(a) |
1,944 | 183,203 | ||||||
Xilinx Inc. |
1,076 | 208,260 | ||||||
|
|
|||||||
3,337,163 | ||||||||
Software — 19.6% | ||||||||
C3.ai Inc., Class A(a) |
2,528 | 66,587 | ||||||
Cadence Design Systems Inc.(a) |
1,308 | 198,999 | ||||||
Citrix Systems Inc. |
2,904 | 296,034 | ||||||
Datadog Inc., Class A(a) |
1,316 | 192,281 | ||||||
Dropbox Inc., Class A(a) |
9,528 | 235,818 | ||||||
New Relic Inc.(a) |
2,036 | 214,065 | ||||||
Nutanix Inc., Class A(a) |
6,592 | 180,225 | ||||||
Synopsys Inc.(a) |
660 | 204,930 | ||||||
Teradata Corp.(a)(b) |
3,588 | 144,740 | ||||||
|
|
|||||||
1,733,679 | ||||||||
Technology
Hardware, Storage & |
||||||||
Pure Storage Inc., Class A(a) |
7,204 | 190,834 | ||||||
Wiwynn Corp. |
3,000 | 109,976 | ||||||
|
|
|||||||
300,810 | ||||||||
|
|
|||||||
Total
Common Stocks — 99.8% |
|
8,812,178 | ||||||
|
|
|||||||
Short-Term Investments | ||||||||
Money Market Funds — 1.9% | ||||||||
BlackRock
Cash Funds: Institutional, SL Agency |
168,380 | 168,430 | ||||||
|
|
|||||||
Total
Short-Term Investments — 1.9% |
|
168,430 | ||||||
|
|
|||||||
Total
Investments in Securities — 101.7% |
|
8,980,608 | ||||||
Other Assets, Less Liabilities — (1.7)% |
|
(148,634 | ) | |||||
|
|
|||||||
Net Assets — 100.0% |
|
$ | 8,831,974 | |||||
|
|
(a) |
Non-income producing security. |
(b) |
All or a portion of this security is on loan. |
(c) |
Affiliate of the Fund. |
(d) |
Annualized 7-day yield as of period end. |
(e) |
All or a portion of this security was purchased with the cash collateral from loaned securities. |
S C H E D U L E O F I N V E S T M E N T S |
13 |
Schedule of Investments (unaudited) (continued) January 31, 2022 |
iShares® Cloud 5G and Tech ETF |
Affiliates
Investments in issuers considered to be affiliate(s) of the Fund during the six months ended January 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:
Affiliated Issuer | Value at 07/31/21 |
Purchases at Cost |
Proceeds from Sales |
Net Realized Gain (Loss) |
Change
in Unrealized Appreciation (Depreciation) |
Value at 01/31/22 |
Shares Held at 01/31/22 |
Income |
Capital Gain |
|||||||||||||||||||||||||||
BlackRock
Cash Funds: Institutional, |
$ | — | $ | 168,430 | (a) | $ | — | $ | — | $ | — | $ | 168,430 | 168,380 | $ | 24 | (b) | $ | — | |||||||||||||||||
BlackRock
Cash Funds: Treasury, |
10,000 | — | (10,000 | )(a) | — | — | — | — | — | — | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
$ | — | $ | — | $ | 168,430 | $ | 24 | $ | — | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
(a) |
Represents net amount purchased (sold). |
(b) |
All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities. |
(c) |
As of period end, the entity is no longer held. |
Fair Value Hierarchy as of Period End
Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.
The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.
|
||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
|
||||||||||||||||
Investments |
||||||||||||||||
Assets |
||||||||||||||||
Common Stocks |
$ | 5,990,996 | $ | 2,821,182 | $ | — | $ | 8,812,178 | ||||||||
Money Market Funds |
168,430 | — | — | 168,430 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | 6,159,426 | $ | 2,821,182 | $ | — | $ | 8,980,608 | |||||||||
|
|
|
|
|
|
|
|
See notes to financial statements.
14 |
2 0 2 2 I S H A R E S S E M I - A N N U A L R E P O R T T O S H A R E H O L D E R S |
Schedule of Investments (unaudited) January 31, 2022 |
iShares® Cybersecurity and Tech ETF (Percentages shown are based on Net Assets) |
Security | Shares | Value | ||||||
Common Stocks |
||||||||
Communications Equipment — 9.6% | ||||||||
Accton Technology Corp |
1,345,000 | $ | 12,988,202 | |||||
ADTRAN Inc |
109,217 | 2,098,058 | ||||||
Calix Inc.(a) |
154,928 | 7,789,780 | ||||||
Juniper Networks Inc |
741,300 | 25,812,066 | ||||||
Radware Ltd.(a)(b) |
110,022 | 3,700,040 | ||||||
|
|
|||||||
52,388,146 | ||||||||
IT Services — 9.0% | ||||||||
Akamai Technologies Inc.(a)(b) |
209,505 | 23,998,798 | ||||||
My EG Services Bhd |
10,940,100 | 2,551,355 | ||||||
Okta Inc.(a)(b) |
106,042 | 20,984,651 | ||||||
Secunet Security Networks AG |
3,585 | 1,276,491 | ||||||
|
|
|||||||
48,811,295 | ||||||||
Professional Services — 9.7% | ||||||||
Booz Allen Hamilton Holding Corp. |
261,804 | 20,088,221 | ||||||
CACI International Inc., Class A(a) |
62,950 | 15,577,607 | ||||||
ManTech International Corp./VA, Class A |
58,183 | 4,203,140 | ||||||
Science Applications International Corp. |
156,651 | 12,850,082 | ||||||
|
|
|||||||
52,719,050 | ||||||||
Software — 71.4% | ||||||||
A10 Networks Inc. |
201,760 | 2,986,047 | ||||||
Absolute Software Corp. |
98,901 | 797,495 | ||||||
Ahnlab Inc.(b) |
16,844 | 1,087,349 | ||||||
Alarm.com Holdings Inc.(a) |
122,694 | 9,149,291 | ||||||
Allot Ltd.(a) |
87,043 | 835,613 | ||||||
BlackBerry Ltd.(a) |
1,469,320 | 12,090,695 | ||||||
Check Point Software Technologies Ltd.(a) |
208,776 | 25,263,984 | ||||||
Citrix Systems Inc |
292,844 | 29,852,517 | ||||||
Clear Secure Inc., Class A(a)(b) |
185,872 | 4,589,180 | ||||||
Cognyte Software Ltd.(a) |
194,838 | 2,113,992 | ||||||
Crowdstrike Holdings Inc., Class A(a) |
116,597 | 21,062,082 | ||||||
CyberArk Software Ltd.(a)(b) |
105,988 | 14,536,254 | ||||||
Darktrace PLC(a) |
830,697 | 4,602,118 | ||||||
Digital Arts Inc. |
28,200 | 1,661,479 | ||||||
DocuSign Inc.(a) |
159,878 | 20,107,856 | ||||||
Everbridge Inc.(a) |
81,766 | 4,179,878 | ||||||
Fortinet Inc.(a) |
76,342 | 22,691,896 | ||||||
Kape Technologies PLC(a) |
298,996 | 1,492,770 | ||||||
KnowBe4 Inc., Class A(a)(b) |
58,395 | 1,396,808 | ||||||
Mandiant Inc.(a)(b) |
630,123 | 9,508,556 | ||||||
McAfee Corp., Class A |
247,992 | 6,360,995 | ||||||
Micro Focus International PLC |
967,488 | 5,952,109 | ||||||
Mimecast Ltd.(a) |
167,125 | 13,321,534 | ||||||
Netcompany Group A/S(c) |
121,302 | 8,911,360 |
Security | Shares | Value | ||||||
Software (continued) | ||||||||
OneSpan Inc.(a) |
89,299 | $ | 1,434,142 | |||||
Palo Alto Networks Inc.(a)(b) |
44,264 | 22,902,194 | ||||||
Ping Identity Holding Corp.(a) |
189,870 | 3,757,527 | ||||||
Qualys Inc.(a)(b) |
94,342 | 12,088,984 | ||||||
Rapid7 Inc.(a)(b) |
147,017 | 14,162,148 | ||||||
SailPoint Technologies Holdings Inc.(a)(b) |
243,698 | 9,428,676 | ||||||
SentinelOne Inc., Class A(a)(b) |
99,675 | 4,460,456 | ||||||
TeamViewer AG(a)(c) |
429,799 | 6,494,278 | ||||||
Telos Corp.(a) |
143,464 | 1,677,094 | ||||||
Tenable Holdings Inc.(a) |
279,051 | 14,343,221 | ||||||
Trend Micro Inc/Japan(a) |
367,500 | 19,496,828 | ||||||
Varonis Systems Inc.(a) |
252,387 | 9,403,940 | ||||||
VMware Inc., Class A |
194,623 | 25,005,163 | ||||||
Zscaler Inc.(a) |
73,172 | 18,813,253 | ||||||
|
|
|||||||
388,019,762 | ||||||||
|
|
|||||||
Total
Common Stocks — 99.7% |
541,938,253 | |||||||
|
|
|||||||
Short-Term Investments |
||||||||
Money Market Funds — 8.8% |
||||||||
BlackRock Cash Funds: Institutional, SL Agency Shares, 0.08%(d)(e)(f) |
46,805,116 | 46,819,158 | ||||||
BlackRock Cash Funds: Treasury, SL Agency Shares, 0.00%(d)(e) |
950,000 | 950,000 | ||||||
|
|
|||||||
47,769,158 | ||||||||
|
|
|||||||
Total Short-Term Investments — 8.8% (Cost: $47,768,655) |
47,769,158 | |||||||
|
|
|||||||
Total Investments in Securities — 108.5% (Cost: $584,482,118) |
589,707,411 | |||||||
Other Assets, Less Liabilities — (8.5)% |
(46,256,095 | ) | ||||||
|
|
|||||||
Net Assets — 100.0% |
$ | 543,451,316 | ||||||
|
|
(a) |
Non-income producing security. |
(b) |
All or a portion of this security is on loan. |
(c) |
Security exempt from registration pursuant to Rule 144A under the Securities Act of 1933, as amended. These securities may be resold in transactions exempt from registration to qualified institutional investors. |
(d) |
Affiliate of the Fund. |
(e) |
Annualized 7-day yield as of period end. |
(f) |
All or a portion of this security was purchased with the cash collateral from loaned securities. |
S C H E D U L E O F I N V E S T M E N T S |
15 |
Schedule of Investments (unaudited) (continued) January 31, 2022 |
iShares® Cybersecurity and Tech ETF |
Affiliates
Investments in issuers considered to be affiliate(s) of the Fund during the six months ended January 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:
Affiliated Issuer | Value at 07/31/21 |
Purchases at Cost |
Proceeds from Sales |
Net Realized Gain (Loss) |
Change
in Unrealized Appreciation (Depreciation) |
Value at 01/31/22 |
Shares Held at 01/31/22 |
Income |
Capital Gain |
|||||||||||||||||||||||||||
BlackRock
Cash Funds: Institutional, |
$ | 62,729,133 | $ | — | $ | (15,900,402 | )(a) | $ | (9,490 | ) | $ | (83 | ) | $ | 46,819,158 | 46,805,116 | $ | 222,324 | (b) | $ | — | |||||||||||||||
BlackRock
Cash Funds: Treasury, |
790,000 | 160,000 | (a) | — | — | — | 950,000 | 950,000 | 26 | — | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
$ | (9,490 | ) | $ | (83 | ) | $ | 47,769,158 | $ | 222,350 | $ | — | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
(a) |
Represents net amount purchased (sold). |
(b) |
All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities. |
Derivative Financial Instruments Outstanding as of Period End
Futures Contracts
|
||||||||||||||||
Description | Number of Contracts |
Expiration Date |
Notional Amount (000) |
Value/ Unrealized Appreciation (Depreciation) |
||||||||||||
|
||||||||||||||||
Long Contracts |
||||||||||||||||
E-Mini Technology Select Sector Index |
8 | 03/18/22 | $ | 1,304 | $ | (53,658 | ) | |||||||||
|
|
Derivative Financial Instruments Categorized by Risk Exposure
As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:
|
||||
Equity Contracts |
||||
|
||||
Liabilities — Derivative Financial Instruments |
||||
Futures contracts |
||||
Unrealized depreciation on futures contracts(a) |
$ | 53,658 | ||
|
|
(a) |
Net cumulative unrealized appreciation (depreciation) on futures contracts are reported in the Schedule of Investments. In the Statements of Assets and Liabilities, only current day’s variation margin is reported in receivables or payables and the net cumulative unrealized appreciation (depreciation) is included in accumulated earnings (loss). |
For the period ended January 31, 2022, the effect of derivative financial instruments in the Statements of Operations was as follows:
Equity Contracts |
||||
Net Realized Gain (Loss) from: |
||||
Futures contracts |
$ | 168,812 | ||
|
|
|||
Net Change in Unrealized Appreciation (Depreciation) on: |
||||
Futures contracts |
$ | (112,078 | ) | |
|
|
Average Quarterly Balances of Outstanding Derivative Financial Instruments
Futures contracts: |
||||
Average notional value of contracts — long |
$ | 692,177 |
For more information about the Fund’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.
16 |
2 0 2 2 I S H A R E S S E M I - A N N U A L R E P O R T T O S H A R E H O L D E R S |
Schedule of Investments (unaudited) (continued) January 31, 2022 |
iShares® Cybersecurity and Tech ETF |
Fair Value Hierarchy as of Period End
Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.
The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Investments |
||||||||||||||||
Assets |
||||||||||||||||
Common Stocks |
$ | 475,423,914 | $ | 66,514,339 | $ | — | $ | 541,938,253 | ||||||||
Money Market Funds |
47,769,158 | — | — | 47,769,158 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | 523,193,072 | $ | 66,514,339 | $ | — | $ | 589,707,411 | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Derivative financial instruments(a) |
||||||||||||||||
Liabilities |
||||||||||||||||
Futures Contracts |
$ | (53,658 | ) | $ | — | $ | — | $ | (53,658 | ) | ||||||
|
|
|
|
|
|
|
|
(a) |
Derivative financial instruments are futures contracts. Futures contracts are valued at the unrealized appreciation (depreciation) on the instrument. |
See notes to financial statements.
S C H E D U L E O F I N V E S T M E N T S |
17 |
Schedule of Investments (unaudited) January 31, 2022 |
iShares® Exponential Technologies ETF (Percentages shown are based on Net Assets) |
Security |
Shares |
Value | ||||||
Common Stocks |
||||||||
Australia — 3.3% | ||||||||
IRESS Ltd. |
2,335,065 | $ | 18,890,284 | |||||
Megaport Ltd.(a) |
1,478,706 | 14,224,813 | ||||||
Nanosonics Ltd.(a) |
4,963,785 | 18,042,370 | ||||||
Netwealth Group Ltd. |
1,837,130 | 19,897,096 | ||||||
NEXTDC Ltd.(a) |
2,458,512 | 18,864,079 | ||||||
Technology One Ltd. |
2,357,500 | 17,636,470 | ||||||
WiseTech Global Ltd. |
558,313 | 18,183,892 | ||||||
|
|
|||||||
125,739,004 | ||||||||
Canada — 1.9%pg8 | ||||||||
Bausch Health Cos Inc.(a) |
835,098 | 20,530,081 | ||||||
BlackBerry Ltd.(a) |
2,290,381 | 18,847,017 | ||||||
Descartes Systems Group Inc. (The)(a) |
261,067 | 18,993,412 | ||||||
Shopify Inc., Class A(a) |
13,816 | 13,335,595 | ||||||
|
|
|||||||
71,706,105 | ||||||||
China — 5.6% | ||||||||
3SBio Inc.(a)(b) |
24,281,000 | 19,225,533 | ||||||
Alibaba Group Holding Ltd.(a) |
1,367,300 | 21,430,461 | ||||||
Baidu Inc.(a) |
1,148,950 | 22,759,413 | ||||||
China Datang Corp. Renewable Power Co. Ltd., Class H |
51,994,000 | 21,098,026 | ||||||
China Longyuan Power Group Corp. Ltd., Class H |
10,063,000 | 20,531,420 | ||||||
China Resources Power Holdings Co. Ltd. |
6,878,000 | 16,749,871 | ||||||
Genscript Biotech Corp.(a) |
4,036,000 | 12,856,338 | ||||||
I-Mab, ADR(a) |
391,711 | 9,890,703 | ||||||
Innovent Biologics Inc.(a)(b) |
2,509,500 | 10,627,244 | ||||||
JD.com Inc., Class A(a) |
16,804 | 636,895 | ||||||
Shanghai Junshi Biosciences Co. Ltd., Class A(a) |
2,289,284 | 21,244,946 | ||||||
Tencent Holdings Ltd. |
352,900 | 22,113,517 | ||||||
Wuxi Biologics Cayman Inc., New(a)(b) |
1,616,500 | 16,201,798 | ||||||
|
|
|||||||
215,366,165 | ||||||||
Denmark — 0.9% | ||||||||
Orsted A/S(b) |
166,088 | 17,695,845 | ||||||
Vestas Wind Systems A/S |
670,417 | 18,141,747 | ||||||
|
|
|||||||
35,837,592 | ||||||||
Finland — 1.1% | ||||||||
Nokia OYJ(a) |
3,613,839 | 21,551,576 | ||||||
Wartsila OYJ Abp |
1,514,220 | 18,695,176 | ||||||
|
|
|||||||
40,246,752 | ||||||||
France — 1.6% | ||||||||
Capgemini SE |
93,421 | 21,002,569 | ||||||
Dassault Systemes SE |
336,903 | 16,292,081 | ||||||
Sanofi |
212,995 | 22,271,185 | ||||||
|
|
|||||||
59,565,835 | ||||||||
Germany — 1.5% | ||||||||
Infineon Technologies AG |
456,757 | 18,968,087 | ||||||
Merck KGaA |
83,555 | 18,323,467 | ||||||
SAP SE |
159,575 | 20,020,472 | ||||||
|
|
|||||||
57,312,026 | ||||||||
India — 1.6% | ||||||||
Infosys Ltd. |
905,567 | 21,305,909 | ||||||
Tata Consultancy Services Ltd. |
427,103 | 21,507,123 | ||||||
Wipro Ltd. |
2,513,364 | 19,405,359 | ||||||
|
|
|||||||
62,218,391 | ||||||||
Israel — 0.5% | ||||||||
Nice Ltd.(a) |
68,688 | 17,582,591 | ||||||
|
|
Security |
Shares | Value | ||||||
Japan — 7.1% | ||||||||
Chugai Pharmaceutical Co. Ltd. |
623,600 | $ | 20,254,380 | |||||
Denso Corp. |
264,100 | 19,710,755 | ||||||
FANUC Corp. |
97,200 | 19,221,136 | ||||||
Harmonic Drive Systems Inc. |
506,200 | 20,021,573 | ||||||
Murata Manufacturing Co. Ltd. |
272,000 | 20,449,849 | ||||||
Nabtesco Corp. |
756,300 | 23,641,155 | ||||||
Nidec Corp. |
177,200 | 15,705,200 | ||||||
Rakuten Group Inc.(a) |
2,093,700 | 18,163,632 | ||||||
SoftBank Group Corp. |
445,411 | 19,731,502 | ||||||
Taiyo Yuden Co. Ltd. |
368,700 | 17,908,198 | ||||||
Takeda Pharmaceutical Co. Ltd. |
782,304 | 22,673,661 | ||||||
TDK Corp. |
522,100 | 18,855,579 | ||||||
Tokyo Electron Ltd. |
38,100 | 18,635,966 | ||||||
Yaskawa Electric Corp. |
408,000 | 17,083,108 | ||||||
|
|
|||||||
272,055,694 | ||||||||
Netherlands — 3.4% | ||||||||
Adyen NV(a)(b) |
7,415 | 15,088,765 | ||||||
ASM International NV |
50,890 | 17,484,805 | ||||||
ASML Holding NV |
26,484 | 17,937,467 | ||||||
NXP Semiconductors NV |
95,912 | 19,704,161 | ||||||
QIAGEN NV(a) |
369,705 | 18,275,347 | ||||||
STMicroelectronics NV |
455,036 | 21,396,125 | ||||||
TomTom NV(a)(c) |
2,245,430 | 21,458,308 | ||||||
|
|
|||||||
131,344,978 | ||||||||
Singapore — 0.5% | ||||||||
Keppel DC REIT |
11,947,900 | 18,966,016 | ||||||
|
|
|||||||
South Korea — 1.0% | ||||||||
Samsung SDI Co. Ltd. |
35,478 | 17,607,154 | ||||||
SK Hynix Inc. |
210,746 | 21,813,845 | ||||||
|
|
|||||||
39,420,999 | ||||||||
Spain — 0.5% | ||||||||
Siemens Gamesa Renewable Energy SA(a) |
843,821 | 18,258,486 | ||||||
|
|
|||||||
Sweden — 1.3% | ||||||||
Subsea 7 SA |
2,951,177 | 22,187,748 | ||||||
Telefonaktiebolaget LM Ericsson, Class B |
2,051,332 | 25,613,123 | ||||||
|
|
|||||||
47,800,871 | ||||||||
Switzerland — 2.1% | ||||||||
ABB Ltd., Registered |
576,179 | 19,977,150 | ||||||
CRISPR Therapeutics AG(a) |
269,393 | 17,173,804 | ||||||
Novartis AG, Registered |
255,487 | 22,199,135 | ||||||
Roche Holding AG, NVS |
49,853 | 19,293,069 | ||||||
|
|
|||||||
78,643,158 | ||||||||
Taiwan — 2.2% | ||||||||
Hon Hai Precision Industry Co. Ltd. |
5,464,000 | 20,429,496 | ||||||
MediaTek Inc. |
540,000 | 21,448,362 | ||||||
Taiwan Semiconductor Manufacturing Co. Ltd. |
977,000 | 22,590,181 | ||||||
Win Semiconductors Corp. |
1,648,000 | 20,415,902 | ||||||
|
|
|||||||
84,883,941 | ||||||||
United Kingdom — 3.6% | ||||||||
Aptiv PLC(a) |
121,458 | 16,588,734 | ||||||
AstraZeneca PLC |
197,197 | 22,939,520 | ||||||
GlaxoSmithKline PLC |
993,886 | 22,179,545 | ||||||
Ocado Group PLC(a) |
981,192 | 19,992,350 | ||||||
Sage Group PLC (The) |
1,920,973 | 18,771,700 | ||||||
Sensata Technologies Holding PLC(a) |
350,413 | 20,099,690 | ||||||
Spirax-Sarco Engineering PLC |
98,266 | 17,713,006 | ||||||
|
|
|||||||
138,284,545 |
18 |
2 0 2 2 I S H A R E S S E M I - A N N U A L R E P O R T T O S H A R E H O L D E R S |
Schedule of Investments (unaudited) (continued) January 31, 2022 |
iShares® Exponential Technologies ETF (Percentages shown are based on Net Assets) |
Security |
Shares |
Value | ||||||
United States — 59.6% | ||||||||
AbbVie Inc. |
169,476 | $ | 23,199,570 | |||||
Accenture PLC, Class A |
55,340 | 19,567,117 | ||||||
Advanced Micro Devices Inc.(a)(c) |
146,922 | 16,785,839 | ||||||
Agilent Technologies Inc. |
132,819 | 18,504,343 | ||||||
Akamai Technologies Inc.(a) |
187,327 | 21,458,308 | ||||||
Albemarle Corp. |
79,287 | 17,501,812 | ||||||
Alnylam Pharmaceuticals Inc.(a) |
119,626 | 16,460,538 | ||||||
Alphabet Inc., Class A(a) |
6,996 | 18,931,666 | ||||||
Amazon.com Inc.(a) |
6,004 | 17,960,786 | ||||||
Analog Devices Inc. |
119,350 | 19,569,819 | ||||||
ANSYS Inc.(a) |
52,209 | 17,751,582 | ||||||
Apple Inc. |
114,940 | 20,089,213 | ||||||
Applied Materials Inc. |
133,649 | 18,467,619 | ||||||
Arista Networks Inc.(a) |
170,545 | 21,200,449 | ||||||
Aspen Technology Inc.(a) |
142,854 | 21,450,957 | ||||||
Autodesk Inc.(a) |
78,191 | 19,531,330 | ||||||
Beam Therapeutics Inc.(a)(c) |
266,642 | 18,454,293 | ||||||
Biogen Inc.(a) |
91,247 | 20,621,822 | ||||||
BioMarin Pharmaceutical Inc.(a) |
233,491 | 20,694,307 | ||||||
Blackbaud Inc.(a) |
265,332 | 18,079,722 | ||||||
BlackRock Inc.(d) |
22,898 | 18,843,680 | ||||||
Block Inc.(a)(c) |
107,852 | 13,189,221 | ||||||
Bristol-Myers Squibb Co. |
375,631 | 24,374,696 | ||||||
Broadcom Inc. |
38,240 | 22,404,051 | ||||||
Broadridge Financial Solutions Inc. |
125,404 | 19,966,825 | ||||||
Cadence Design Systems Inc.(a) |
116,593 | 17,738,459 | ||||||
CF Industries Holdings Inc. |
354,503 | 24,414,622 | ||||||
Cisco Systems Inc. |
369,081 | 20,546,739 | ||||||
Citrix Systems Inc. |
260,412 | 26,546,399 | ||||||
Cogent Communications Holdings Inc. |
268,282 | 17,065,418 | ||||||
Cognizant Technology Solutions Corp., Class A |
255,081 | 21,789,019 | ||||||
Coinbase Global Inc., Class A(a)(c) |
74,061 | 14,082,699 | ||||||
Coupa Software Inc.(a)(c) |
121,986 | 16,379,060 | ||||||
Crowdstrike Holdings Inc., Class A(a) |
100,259 | 18,110,786 | ||||||
Denali Therapeutics Inc.(a)(c) |
444,903 | 15,224,581 | ||||||
DISH Network Corp., Class A(a)(c) |
658,526 | 20,677,716 | ||||||
Dropbox Inc., Class A(a) |
870,723 | 21,550,394 | ||||||
DuPont de Nemours Inc. |
272,309 | 20,858,869 | ||||||
Edwards Lifesciences Corp.(a) |
176,051 | 19,224,769 | ||||||
Eli Lilly & Co. |
86,326 | 21,183,537 | ||||||
Enphase Energy Inc.(a)(c) |
91,395 | 12,838,256 | ||||||
Envestnet Inc.(a)(c) |
230,046 | 17,009,601 | ||||||
Exelixis Inc.(a)(c) |
1,256,709 | 22,746,433 | ||||||
F5 Inc.(a)(c) |
91,281 | 18,951,761 | ||||||
Fastly Inc., Class A(a)(c) |
483,626 | 13,860,721 | ||||||
First Solar Inc.(a) |
205,970 | 16,143,929 | ||||||
Fortinet Inc.(a) |
65,669 | 19,519,454 | ||||||
Gilead Sciences Inc. |
289,398 | 19,875,855 | ||||||
Guardant Health Inc.(a)(c) |
211,416 | 14,703,983 | ||||||
Guidewire Software Inc.(a)(c) |
175,330 | 17,680,277 | ||||||
Hewlett Packard Enterprise Co. |
1,358,787 | 22,188,992 | ||||||
Hubbell Inc. |
107,492 | 20,132,177 | ||||||
Illumina Inc.(a) |
54,781 | 19,108,708 | ||||||
Incyte Corp.(a) |
312,363 | 23,217,942 | ||||||
Intel Corp. |
399,672 | 19,511,987 | ||||||
Intellia Therapeutics Inc.(a) |
176,720 | 16,712,410 | ||||||
International Business Machines Corp. |
173,273 | 23,144,075 | ||||||
Intuit Inc. |
29,963 | 16,636,356 | ||||||
Intuitive Surgical Inc.(a) |
64,892 | 18,441,009 | ||||||
Ionis Pharmaceuticals Inc.(a)(c) |
663,909 | 21,112,306 |
Security |
Shares | Value | ||||||
United States (continued) | ||||||||
Jazz Pharmaceuticals PLC(a)(c) |
170,531 | $ | 23,688,461 | |||||
Johnson & Johnson |
122,835 | 21,163,242 | ||||||
Juniper Networks Inc. |
637,750 | 22,206,455 | ||||||
KLA Corp. |
50,250 | 19,560,817 | ||||||
Lam Research Corp. |
30,063 | 17,734,765 | ||||||
Livent Corp.(a) |
740,946 | 17,049,167 | ||||||
Lumen Technologies Inc. |
1,771,929 | 21,901,042 | ||||||
Mandiant Inc.(a) |
1,267,547 | 19,127,284 | ||||||
Manhattan Associates Inc.(a) |
137,455 | 18,401,101 | ||||||
Marqeta Inc., Class A(a)(c) |
1,108,877 | 13,084,749 | ||||||
MercadoLibre Inc.(a)(c) |
17,284 | 19,566,525 | ||||||
Merck & Co. Inc. |
298,348 | 24,309,395 | ||||||
Meta Platforms Inc, Class A(a) |
65,310 | 20,459,011 | ||||||
Microchip Technology Inc. |
250,916 | 19,440,972 | ||||||
Micron Technology Inc. |
251,018 | 20,651,251 | ||||||
Microsoft Corp. |
63,198 | 19,653,314 | ||||||
Moderna Inc.(a) |
72,396 | 12,258,815 | ||||||
MongoDB Inc.(a) |
39,813 | 16,128,644 | ||||||
Myriad Genetics Inc.(a)(c) |
790,929 | 20,793,523 | ||||||
NortonLifeLock Inc. |
874,460 | 22,744,705 | ||||||
NVIDIA Corp. |
66,387 | 16,255,521 | ||||||
Okta Inc.(a)(c) |
87,113 | 17,238,792 | ||||||
Oracle Corp. |
235,328 | 19,099,220 | ||||||
Palantir Technologies Inc., Class A(a) |
1,038,846 | 14,242,579 | ||||||
Palo Alto Networks Inc.(a)(c) |
39,857 | 20,622,012 | ||||||
Paylocity Holding Corp.(a) |
84,154 | 17,165,733 | ||||||
PayPal Holdings Inc.(a) |
107,076 | 18,410,647 | ||||||
Pegasystems Inc. |
179,358 | 17,795,901 | ||||||
PTC Inc.(a)(c) |
177,541 | 20,640,917 | ||||||
Qorvo Inc.(a) |
125,055 | 17,167,550 | ||||||
QUALCOMM Inc. |
117,106 | 20,582,551 | ||||||
Regeneron Pharmaceuticals Inc.(a) |
32,259 | 19,632,505 | ||||||
RingCentral Inc., Class A(a) |
97,829 | 17,265,840 | ||||||
Rocket Companies Inc., Class A |
1,282,857 | 16,215,312 | ||||||
Sabre Corp.(a) |
2,298,063 | 21,027,276 | ||||||
salesforce.com Inc.(a) |
80,963 | 18,834,423 | ||||||
Seagen Inc.(a) |
141,726 | 19,063,564 | ||||||
SEI Investments Co. |
342,495 | 20,073,632 | ||||||
ServiceNow Inc.(a) |
32,151 | 18,833,413 | ||||||
Shoals Technologies Group Inc., Class A(a)(c) |
741,032 | 12,493,800 | ||||||
Skyworks Solutions Inc. |
128,124 | 18,772,728 | ||||||
Snowflake Inc., Class A(a) |
56,557 | 15,604,076 | ||||||
SoFi Technologies Inc.(a)(c) |
1,223,464 | 15,268,831 | ||||||
SolarEdge Technologies Inc.(a) |
62,068 | 14,785,839 | ||||||
Splunk Inc.(a) |
177,818 | 22,035,207 | ||||||
SS&C Technologies Holdings Inc. |
276,904 | 22,116,322 | ||||||
Synaptics Inc.(a) |
73,189 | 15,395,306 | ||||||
Synopsys Inc.(a) |
58,406 | 18,135,063 | ||||||
TE Connectivity Ltd. |
141,554 | 20,243,638 | ||||||
Teladoc Health Inc.(a)(c) |
207,504 | 15,917,632 | ||||||
Tesla Inc.(a) |
19,784 | 18,532,068 | ||||||
Texas Instruments Inc. |
110,513 | 19,835,978 | ||||||
Thermo Fisher Scientific Inc. |
32,891 | 19,119,538 | ||||||
Twilio Inc., Class A(a) |
77,139 | 15,899,891 | ||||||
Tyler Technologies Inc.(a)(c) |
39,702 | 18,810,808 | ||||||
Veoneer Inc.(a)(c) |
596,421 | 20,999,983 | ||||||
VMware Inc., Class A |
184,434 | 23,696,080 | ||||||
Xilinx Inc. |
94,370 | 18,265,314 | ||||||
Zendesk Inc.(a)(c) |
204,652 | 20,160,269 |
S C H E D U L E O F I N V E S T M E N T S |
19 |
Schedule of Investments (unaudited) (continued) January 31, 2022 |
iShares® Exponential Technologies ETF (Percentages shown are based on Net Assets) |
Security | Shares | Value | ||||||
United States (continued) | ||||||||
Zscaler Inc.(a) |
68,307 | $ | 17,562,413 | |||||
|
|
|||||||
2,277,730,274 | ||||||||
|
|
|||||||
Total
Common Stocks — 99.3% |
3,792,963,423 | |||||||
|
|
|||||||
Preferred Stocks |
| |||||||
Chile — 0.5% | ||||||||
Sociedad Quimica y Minera de Chile SA, Class B, Preference Shares |
366,159 | 19,609,242 | ||||||
|
|
|||||||
Total
Preferred Stocks — 0.5% |
19,609,242 | |||||||
|
|
|||||||
Short-Term Investments |
| |||||||
Money Market Funds — 3.4% | ||||||||
BlackRock Cash Funds: Institutional, SL Agency Shares, 0.08%(d)(e)(f) |
126,349,124 | 126,387,029 | ||||||
BlackRock Cash Funds: Treasury, SL Agency Shares, 0.00%(d)(e) |
4,530,000 | 4,530,000 | ||||||
|
|
|||||||
130,917,029 | ||||||||
|
|
|||||||
Total
Short-Term Investments — 3.4% |
130,917,029 | |||||||
|
|
|||||||
Total Investments in Securities — 103.2% |
3,943,489,694 | |||||||
Other Assets, Less Liabilities — (3.2)% |
(121,117,970 | ) | ||||||
|
|
|||||||
Net Assets — 100.0% |
$ | 3,822,371,724 | ||||||
|
|
(a) |
Non-income producing security. |
(b) |
Security exempt from registration pursuant to Rule 144A under the Securities Act of 1933, as amended. These securities may be resold in transactions exempt from registration to qualified institutional investors. |
(c) |
All or a portion of this security is on loan. |
(d) |
Affiliate of the Fund. |
(e) |
Annualized 7-day yield as of period end. |
(f) |
All or a portion of this security was purchased with the cash collateral from loaned securities. |
Affiliates
Investments in issuers considered to be affiliate(s) of the Fund during the six months ended January 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:
|
||||||||||||||||||||||||||||||||||||
Affiliated Issuer | Value
at 07/31/21 |
Purchases at Cost |
Proceeds from Sales |
Net Realized Gain (Loss) |
Change
in Unrealized Appreciation (Depreciation) |
Value
at 01/31/22 |
Shares Held at 01/31/22 |
Income | Capital Gain Distributions from Underlying Funds |
|||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
BlackRock Cash Funds: Institutional, SL Agency Shares |
$ | 29,091,609 | $ | 97,303,544 | (a) | $ | — | $ | (3,179 | ) | $ | (4,945) | $ | 126,387,029 | 126,349,124 | $ | 61,035 | (b) | $ | — | ||||||||||||||||
BlackRock Cash Funds: Treasury, SL Agency Shares |
12,950,000 | — | (8,420,000 | )(a) | — | — | 4,530,000 | 4,530,000 | 147 | — | ||||||||||||||||||||||||||
BlackRock Inc |
21,333,249 | 1,641,426 | (3,182,834 | ) | 71,887 | (1,020,048 | ) | 18,843,680 | 22,898 | 212,034 | — | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
$ | 68,708 | $ | (1,024,993 | ) | $ | 149,760,709 | $ | 273,216 | $ | — | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
(a) |
Represents net amount purchased (sold). |
(b) |
All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities. |
20 |
2 0 2 2 I S H A R E S S E M I - A N N U A L R E P O R T T O S H A R E H O L D E R S |
Schedule of Investments (unaudited) (continued) January 31, 2022 |
iShares® Exponential Technologies ETF |
Derivative Financial Instruments Outstanding as of Period End
Futures Contracts
Description | Number of Contracts |
Expiration Date |
Notional Amount (000) |
Value/ |
||||||||||||
Long Contracts |
||||||||||||||||
Euro STOXX 50 Index |
21 | 03/18/22 | $ | 987 | $ | (6,956 | ) | |||||||||
MSCI Emerging Markets Index |
33 | 03/18/22 | 2,021 | 7,006 | ||||||||||||
S&P 500 E-Mini Index |
19 | 03/18/22 | 4,279 | (193,973 | ) | |||||||||||
|
|
|||||||||||||||
$ | (193,923 | ) | ||||||||||||||
|
|
Derivative Financial Instruments Categorized by Risk Exposure
As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:
Equity Contracts |
||||
Assets — Derivative Financial Instruments |
||||
Futures contracts |
||||
Unrealized appreciation on futures contracts(a) |
$ | 7,006 | ||
|
|
|||
Liabilities — Derivative Financial Instruments |
||||
Futures contracts |
||||
Unrealized depreciation on futures contracts(a) |
$ | 200,929 | ||
|
|
(a) |
Net cumulative unrealized appreciation (depreciation) on futures contracts are reported in the Schedule of Investments. In the Statements of Assets and Liabilities, only current day’s variation margin is reported in receivables or payables and the net cumulative unrealized appreciation (depreciation) is included in accumulated earnings (loss). |
For the period ended January 31, 2022, the effect of derivative financial instruments in the Statements of Operations was as follows:
Equity Contracts |
||||
Net Realized Gain (Loss) from: |
||||
Futures contracts |
$ | 1,517,781 | ||
|
|
|||
Net Change in Unrealized Appreciation (Depreciation) on: |
||||
Futures contracts |
$ | (249,987 | ) | |
|
|
Average Quarterly Balances of Outstanding Derivative Financial Instruments
Futures contracts: |
||||
Average notional value of contracts — long |
$
|
9,438,463
|
|
For more information about the Fund’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.
Fair Value Hierarchy as of Period End
Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.
S C H E D U L E O F I N V E S T M E N T S |
21 |
Schedule of Investments (unaudited) (continued) January 31, 2022 |
iShares® Exponential Technologies ETF |
Fair Value Hierarchy as of Period End (continued)
The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Investments |
||||||||||||||||
Assets |
||||||||||||||||
Common Stocks |
$ | 2,454,138,417 | $ | 1,338,825,006 | $ | — | $ | 3,792,963,423 | ||||||||
Preferred Stocks |
— | 19,609,242 | — | 19,609,242 | ||||||||||||
Money Market Funds |
130,917,029 | — | — | 130,917,029 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | 2,585,055,446 | $ | 1,358,434,248 | $ | — | $ | 3,943,489,694 | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Derivative financial instruments(a) |
||||||||||||||||
Assets |
||||||||||||||||
Futures Contracts |
$ | 7,006 | $ | — | $ | — | $ | 7,006 | ||||||||
Liabilities |
||||||||||||||||
Futures Contracts |
(193,973 | ) | (6,956 | ) | — | (200,929 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | (186,967 | ) | $ | (6,956 | ) | $ | — | $ | (193,923 | ) | ||||||
|
|
|
|
|
|
|
|
(a) |
Derivative financial instruments are futures contracts. Futures contracts are valued at the unrealized appreciation (depreciation) on the instrument. |
See notes to financial statements.
22 |
2 0 2 2 I S H A R E S S E M I - A N N U A L R E P O R T T O S H A R E H O L D E R S |
Schedule of Investments (unaudited) January 31, 2022 |
iShares® Genomics Immunology and Healthcare ETF (Percentages shown are based on Net Assets) |
Security | Shares | Value | ||||||
Common Stocks |
||||||||
China — 3.1% | ||||||||
BeiGene Ltd.(a)(b) |
450,600 | $ | 8,159,059 | |||||
|
|
|||||||
Denmark — 4.4% | ||||||||
Genmab A/S(a) |
33,086 | 11,266,759 | ||||||
|
|
|||||||
France — 6.5% | ||||||||
Sanofi |
130,356 | 13,630,285 | ||||||
Valneva SE(a)(b) |
187,724 | 3,244,892 | ||||||
|
|
|||||||
16,875,177 | ||||||||
Germany — 6.6% | ||||||||
BioNTech SE, ADR(a) |
35,784 | 6,157,711 | ||||||
Evotec SE(a) |
272,214 | 11,015,056 | ||||||
|
|
|||||||
17,172,767 | ||||||||
Japan — 10.2% | ||||||||
Ono Pharmaceutical Co. Ltd. |
539,600 | 13,086,218 | ||||||
Takeda Pharmaceutical Co. Ltd. |
454,400 | 13,169,959 | ||||||
|
|
|||||||
26,256,177 | ||||||||
Netherlands — 1.0% | ||||||||
CureVac NV(a)(b) |
130,782 | 2,525,400 | ||||||
|
|
|||||||
Switzerland — 4.7% | ||||||||
Roche Holding AG, NVS |
31,240 | 12,089,854 | ||||||
|
|
|||||||
Taiwan — 1.7% | ||||||||
Adimmune Corp. |
739,000 | 1,052,146 | ||||||
Medigen Vaccine Biologics Corp.(a) |
369,000 | 3,363,109 | ||||||
|
|
|||||||
4,415,255 | ||||||||
United Kingdom — 0.4% | ||||||||
Adaptimmune Therapeutics PLC, ADR(a) |
331,428 | 967,770 | ||||||
|
|
|||||||
United States — 61.2% | ||||||||
Agenus Inc.(a) |
541,588 | 1,494,783 | ||||||
Alaunos Therapeutics Inc.(a) |
475,132 | 513,143 | ||||||
Aligos Therapeutics Inc.(a) |
62,906 | 200,671 | ||||||
Allogene Therapeutics Inc.(a) |
160,886 | 1,842,145 | ||||||
Altimmune Inc.(a)(b) |
80,940 | 653,186 | ||||||
Arcturus Therapeutics Holdings Inc.(a) |
54,670 | 1,428,527 | ||||||
Arcus Biosciences Inc.(a) |
101,246 | 3,118,377 | ||||||
Beam Therapeutics Inc.(a)(b) |
129,788 | 8,982,627 | ||||||
Bluebird Bio Inc.(a) |
164,152 | 1,295,159 | ||||||
Blueprint Medicines Corp.(a) |
130,640 | 10,072,344 | ||||||
Coherus Biosciences Inc.(a) |
173,382 | 2,143,002 | ||||||
Cue Biopharma Inc.(a) |
73,982 | 546,727 | ||||||
CytomX Therapeutics Inc.(a)(b) |
150,946 | 694,352 | ||||||
Editas Medicine Inc.(a) |
164,436 | 3,130,861 | ||||||
Exelixis Inc.(a) |
744,790 | 13,480,699 | ||||||
Fate Therapeutics Inc.(a)(b) |
216,550 | 8,988,990 | ||||||
FibroGen Inc.(a) |
204,622 | 3,087,746 |
Security | Shares | Value | ||||||
United States (continued) | ||||||||
Gilead Sciences Inc. |
176,932 | $ | 12,151,690 | |||||
Gossamer Bio Inc.(a) |
133,338 | 1,278,711 | ||||||
Humanigen Inc.(a)(b) |
146,402 | 377,717 | ||||||
Inovio Pharmaceuticals Inc.(a)(b) |
498,988 | 2,065,810 | ||||||
Intellia Therapeutics Inc.(a) |
121,836 | 11,522,030 | ||||||
Invitae Corp.(a)(b) |
538,748 | 6,055,527 | ||||||
Iovance Biotherapeutics Inc.(a) |
329,014 | 5,478,083 | ||||||
Ligand Pharmaceuticals Inc.(a) |
38,340 | 4,778,314 | ||||||
Maravai LifeSciences Holdings Inc., Class A(a) |
263,978 | 7,634,244 | ||||||
Moderna Inc.(a) |
40,186 | 6,804,695 | ||||||
NGM Biopharmaceuticals Inc.(a) |
61,628 | 974,339 | ||||||
Novavax Inc.(a)(b) |
76,680 | 7,184,916 | ||||||
Personalis Inc.(a) |
86,620 | 986,602 | ||||||
Precision BioSciences Inc.(a)(b) |
121,410 | 579,126 | ||||||
RAPT Therapeutics Inc.(a) |
57,368 | 1,240,296 | ||||||
Regeneron Pharmaceuticals Inc.(a) |
19,454 | 11,839,510 | ||||||
Sangamo Therapeutics Inc.(a) |
291,100 | 1,755,333 | ||||||
Twist Bioscience Corp.(a) |
107,778 | 6,404,169 | ||||||
Vaxart Inc.(a) |
300,472 | 1,487,336 | ||||||
Vir Biotechnology Inc.(a)(b) |
169,832 | 5,830,333 | ||||||
|
|
|||||||
158,102,120 | ||||||||
|
|
|||||||
Total
Common Stocks — 99.8% |
257,830,338 | |||||||
|
|
|||||||
Short-Term Investments |
||||||||
Money Market Funds — 4.1% | ||||||||
BlackRock
Cash Funds: Institutional, |
10,268,661 | 10,271,741 | ||||||
BlackRock
Cash Funds: Treasury, |
220,000 | 220,000 | ||||||
|
|
|||||||
10,491,741 | ||||||||
|
|
|||||||
Total
Short-Term Investments — 4.1% |
10,491,741 | |||||||
|
|
|||||||
Total
Investments in Securities — 103.9% |
268,322,079 | |||||||
Other Assets, Less Liabilities — (3.9)% |
(10,092,720 | ) | ||||||
|
|
|||||||
Net Assets — 100.0% |
$ | 258,229,359 | ||||||
|
|
(a) |
Non-income producing security. |
(b) |
All or a portion of this security is on loan. |
(c) |
Affiliate of the Fund. |
(d) |
Annualized 7-day yield as of period end. |
(e) |
All or a portion of this security was purchased with the cash collateral from loaned securities. |
S C H E D U L E O F I N V E S T M E N T S |
23 |
Schedule of Investments (unaudited) (continued) January 31, 2022 |
iShares® Genomics Immunology and Healthcare ETF |
Affiliates
Investments in issuers considered to be affiliate(s) of the Fund during the six months ended January 31, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:)
Affiliated Issuer | Value at 07/31/21 |
Purchases at Cost |
Proceeds from Sales |
Net Realized Gain (Loss) |
Change
in Unrealized Appreciation (Depreciation) |
Value at 01/31/22 |
Shares Held at 01/31/22 |
Income |
Capital Gain |
|||||||||||||||||||||||||||
BlackRock Cash Funds: Institutional, SL Agency Shares |
$ | 14,270,396 | $ | — | $ | (3,997,378 | )(a) | $ | (954 | ) | $ | (323 | ) | $ | 10,271,741 | 10,268,661 | $ | 53,525 | (b) | $ | — | |||||||||||||||
BlackRock Cash Funds: Treasury, SL Agency Shares |
200,000 | 20,000 | (a) | — | — | — | 220,000 | 220,000 | 11 | — | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
$ | (954 | ) | $ | (323 | ) | $ | 10,491,741 | $ | 53,536 | $ | — | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
(a) |
Represents net amount purchased (sold). |
(b) |
All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities. |
Derivative Financial Instruments Outstanding as of Period End
Futures Contracts
Description | Number of Contracts |
Expiration Date |
Notional Amount (000) |
Value/ Unrealized Appreciation (Depreciation) |
||||||||||||
Long Contracts |
||||||||||||||||
E-Mini Health Care Sector Index |
3 | 03/18/22 | $ | 397 | $ | (12,787 | ) | |||||||||
|
|
Derivative Financial Instruments Categorized by Risk Exposure
As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:
Equity Contracts |
||||
Liabilities — Derivative Financial Instruments |
||||
Futures contracts |
||||
Unrealized depreciation on futures contracts(a) |
$ | 12,787 | ||
|
|
(a) |
Net cumulative unrealized appreciation (depreciation) on futures contracts are reported in the Schedule of Investments. In the Statements of Assets and Liabilities, only current day’s variation margin is reported in receivables or payables and the net cumulative unrealized appreciation (depreciation) is included in accumulated earnings (loss). |
For the period ended January 31, 2022, the effect of derivative financial instruments in the Statements of Operations was as follows:
Equity Contracts |
||||
Net Realized Gain (Loss) from: |
||||
Futures contracts |
$ | 20,915 | ||
|
|
|||
Net Change in Unrealized Appreciation (Depreciation) on: |
||||
Futures contracts |
$ | (20,197 | ) | |
|
|
Average Quarterly Balances of Outstanding Derivative Financial Instruments
Futures contracts: |
||||
Average notional value of contracts — long |
$
|
401,117
|
|
For more information about the Fund’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.
24 |
2 0 2 2 I S H A R E S S E M I - A N N U A L R E P O R T T O S H A R E H O L D E R S |
Schedule of Investments (unaudited) (continued) January 31, 2022 |
iShares® Genomics Immunology and Healthcare ETF |
Fair Value Hierarchy as of Period End
Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.
The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Investments |
||||||||||||||||
Assets |
||||||||||||||||
Common Stocks |
$ | 172,168,256 | $ | 85,662,082 | $ | — | $ | 257,830,338 | ||||||||
Money Market Funds |
10,491,741 | — | — | 10,491,741 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | 182,659,997 | $ | 85,662,082 | $ | — | $ | 268,322,079 | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Derivative financial instruments(a) |
||||||||||||||||
Liabilities |
||||||||||||||||
Futures Contracts |
$ | (12,787 | ) | $ | — | $ | — | $ | (12,787 | ) | ||||||
|
|
|
|
|
|
|
|
(a) |
Derivative financial instruments are futures contracts. Futures contracts are valued at the unrealized appreciation (depreciation) on the instrument. |
See notes to financial statements.
S C H E D U L E O F I N V E S T M E N T S |
25 |
Schedule of Investments (unaudited) January 31, 2022 |
iShares® Robotics and Artificial Intelligence Multisector ETF (Percentages shown are based on Net Assets) |
Security | Shares | Value | ||||||
Common Stocks |
||||||||
Australia — 0.6% | ||||||||
Megaport Ltd.(a) |
244,743 | $ | 2,354,372 | |||||
|
|
|||||||
Canada — 1.2% | ||||||||
ATS Automation Tooling Systems Inc.(a) |
107,835 | 4,402,815 | ||||||
|
|
|||||||
China — 13.5% | ||||||||
Alibaba Group Holding Ltd.(a) |
224,400 | 3,517,147 | ||||||
Baidu Inc.(a) |
195,100 | 3,864,713 | ||||||
DouYu International Holdings Ltd., ADR(a) |
1,513,656 | 3,178,678 | ||||||
Hello Group Inc., ADR |
376,343 | 3,661,817 | ||||||
HUYA Inc., ADR(a) |
534,371 | 3,537,536 | ||||||
iQIYI Inc., ADR(a)(b) |
729,512 | 2,976,409 | ||||||
JD.com Inc., Class A(a) |
2,433 | 92,214 | ||||||
JOYY Inc., ADR |
83,724 | 4,233,085 | ||||||
Kingsoft Cloud Holdings Ltd., ADR(a)(b) |
103,836 | 877,414 | ||||||
Kuaishou Technology(a)(c) |
356,400 | 4,073,921 | ||||||
Shanghai MicroPort MedBot Group Co. Ltd.(a)(b) |
539,000 | 3,312,684 | ||||||
Tencent Holdings Ltd. |
49,300 | 3,089,250 | ||||||
Tencent Music Entertainment Group, ADR(a) |
567,935 | 3,509,838 | ||||||
Weibo Corp., ADR(a) |
73,857 | 2,559,145 | ||||||
Xiaomi Corp., Class B(a)(c) |
1,550,000 | 3,288,121 | ||||||
ZTE Corp., Class H |
1,435,800 | 3,879,876 | ||||||
|
|
|||||||
49,651,848 | ||||||||
France — 3.0% | ||||||||
Atos SE |
31,595 | 1,132,584 | ||||||
Dassault Systemes SE |
60,031 | 2,903,001 | ||||||
Somfy SA, NVS |
14,722 | 2,710,562 | ||||||
Vivendi SE |
335,328 | 4,394,597 | ||||||
|
|
|||||||
11,140,744 | ||||||||
Germany — 1.8% | ||||||||
Duerr AG |
82,589 | 3,655,004 | ||||||
Nemetschek SE |
30,022 | 2,774,998 | ||||||
|
|
|||||||
6,430,002 | ||||||||
Israel — 2.6% | ||||||||
Maytronics Ltd. |
134,328 | 2,878,672 | ||||||
Nano Dimension Ltd., ADR(a) |
860,150 | 3,156,750 | ||||||
Stratasys Ltd.(a)(b) |
146,490 | 3,492,322 | ||||||
|
|
|||||||
9,527,744 | ||||||||
Japan — 10.7% | ||||||||
FANUC Corp. |
18,500 | 3,658,344 | ||||||
Harmonic Drive Systems Inc. |
67,200 | 2,657,941 | ||||||
Hitachi Ltd. |
59,400 | 3,087,375 | ||||||
Kawasaki Heavy Industries Ltd. |
213,700 | 4,141,195 | ||||||
Kyocera Corp. |
63,800 | 3,934,629 | ||||||
MinebeaMitsumi Inc. |
133,900 | 3,276,611 | ||||||
Nidec Corp. |
32,600 | 2,889,331 | ||||||
Oracle Corp. Japan |
40,000 | 2,991,622 | ||||||
Ricoh Co. Ltd. |
386,200 | 3,261,232 | ||||||
Sharp Corp./Japan |
325,000 | 3,612,736 | ||||||
Sony Group Corp. |
27,000 | 3,020,448 | ||||||
Yaskawa Electric Corp. |
72,400 | 3,031,414 | ||||||
|
|
|||||||
39,562,878 | ||||||||
Netherlands — 2.2% | ||||||||
Stellantis NV |
195,256 | 3,770,172 | ||||||
STMicroelectronics NV |
73,498 | 3,455,930 | ||||||
Yandex NV, Class A(a) |
21,031 | 1,010,750 | ||||||
|
|
|||||||
8,236,852 |
Security | Shares | Value | ||||||
South Korea — 3.5% | ||||||||
AfreecaTV Co. Ltd. |
20,856 | $ | 2,736,016 | |||||
LG Electronics Inc. |
33,962 | 3,689,716 | ||||||
Samsung Electronics Co. Ltd. |
59,876 | 3,724,232 | ||||||
Samsung SDS Co. Ltd. |
21,821 | 2,590,258 | ||||||
|
|
|||||||
12,740,222 | ||||||||
Sweden — 1.6% | ||||||||
Spotify Technology SA(a)(b) |
16,702 | 3,277,935 | ||||||
Surgical Science Sweden AB(a) |
118,023 | 2,531,319 | ||||||
|
|
|||||||
5,809,254 | ||||||||
Taiwan — 7.8% | ||||||||
Alchip Technologies Ltd. |
95,000 | 3,295,805 | ||||||
Faraday Technology Corp. |
493,000 | 3,706,195 | ||||||
Global Unichip Corp. |
161,000 | 2,826,944 | ||||||
Hiwin Technologies Corp. |
367,000 | 3,553,395 | ||||||
Holtek Semiconductor Inc. |
870,000 | 3,241,373 | ||||||
HTC Corp.(a) |
1,119,000 | 2,648,662 | ||||||
Nuvoton Technology Corp. |
609,000 | 3,245,383 | ||||||
RDC Semiconductor Co. Ltd.(a) |
210,000 | 3,626,289 | ||||||
Via Technologies Inc. |
1,050,000 | 2,629,404 | ||||||
|
|
|||||||
28,773,450 | ||||||||
United Kingdom — 1.6% | ||||||||
AVEVA Group PLC |
92,839 | 3,684,020 | ||||||
Clarivate PLC(a)(b) |
137,600 | 2,264,896 | ||||||
|
|
|||||||
5,948,916 | ||||||||
United States — 49.7% | ||||||||
3D Systems Corp.(a)(b) |
165,590 | 2,964,061 | ||||||
Adobe Inc.(a)(b) |
6,019 | 3,215,952 | ||||||
Advanced Micro Devices Inc.(a) |
23,920 | 2,732,860 | ||||||
Alphabet Inc., Class A(a) |
1,292 | 3,496,242 | ||||||
Altair Engineering Inc., Class A(a) |
57,575 | 3,622,619 | ||||||
Alteryx Inc., Class A(a) |
55,015 | 3,139,706 | ||||||
Altra Industrial Motion Corp. |
70,553 | 3,406,299 | ||||||
Amazon.com Inc.(a) |
1,051 | 3,144,035 | ||||||
Ambarella Inc.(a) |
17,594 | 2,465,799 | ||||||
AMETEK Inc. |
22,082 | 3,020,155 | ||||||
Analog Devices Inc. |
17,448 | 2,860,949 | ||||||
ANSYS Inc.(a) |
9,747 | 3,314,078 | ||||||
Apple Inc. |
17,716 | 3,096,403 | ||||||
Autodesk Inc.(a)(b) |
14,942 | 3,732,362 | ||||||
Bentley Systems Inc., Class B |
82,088 | 3,297,475 | ||||||
Bumble Inc., Class A(a) |
113,600 | 3,352,336 | ||||||
CEVA Inc.(a) |
84,898 | 3,198,108 | ||||||
Cognex Corp. |
46,161 | 3,067,860 | ||||||
Concentrix Corp. |
19,201 | 3,859,209 | ||||||
Desktop Metal Inc., Class A(a) |
643,141 | 2,630,447 | ||||||
Domo Inc., Class B(a) |
70,719 | 3,320,964 | ||||||
Dropbox Inc., Class A(a) |
158,463 | 3,921,959 | ||||||
Elastic NV(a) |
30,275 | 2,823,144 | ||||||
FARO Technologies Inc.(a)(b) |
52,254 | 2,837,915 | ||||||
Freshworks Inc.(a) |
127,395 | 2,770,841 | ||||||
fuboTV Inc.(a)(b) |
71,574 | 768,705 | ||||||
GoDaddy Inc., Class A(a) |
56,186 | 4,253,842 | ||||||
HubSpot Inc.(a)(b) |
5,172 | 2,528,074 | ||||||
Informatica Inc.(a)(b) |
108,307 | 3,023,931 | ||||||
Intel Corp. |
69,906 | 3,412,811 | ||||||
International Business Machines Corp. |
31,360 | 4,188,755 | ||||||
Intuitive Surgical Inc.(a) |
11,296 | 3,210,097 | ||||||
iRobot Corp.(a)(b) |
50,200 | 3,289,104 | ||||||
Lattice Semiconductor Corp.(a) |
51,878 | 2,864,703 |
26 |
2 0 2 2 I S H A R E S S E M I - A N N U A L R E P O R T T O S H A R E H O L D E R S |
Schedule of Investments (unaudited) (continued) January 31, 2022 |
iShares® Robotics and Artificial Intelligence Multisector ETF (Percentages shown are based on Net Assets) |
Security | Shares | Value | ||||||
United States (continued) | ||||||||
Lumen Technologies Inc. |
284,374 | $ | 3,514,863 | |||||
Matterport Inc, Class A(a)(b) |
136,603 | 1,329,147 | ||||||
Meta Platforms Inc, Class A(a) |
12,613 | 3,951,148 | ||||||
Microchip Technology Inc. |
39,607 | 3,068,750 | ||||||
Microsoft Corp. |
10,759 | 3,345,834 | ||||||
MicroStrategy Inc., Class A(a)(b) |
5,647 | 2,078,152 | ||||||
Netflix Inc.(a) |
6,002 | 2,563,694 | ||||||
NVIDIA Corp. |
11,664 | 2,856,047 | ||||||
Pegasystems Inc. |
25,382 | 2,518,402 | ||||||
Pinterest Inc., Class A(a) |
45,021 | 1,330,821 | ||||||
Proto Labs Inc.(a) |
73,371 | 3,681,757 | ||||||
PTC Inc.(a) |
27,071 | 3,147,274 | ||||||
QUALCOMM Inc. |
18,559 | 3,261,930 | ||||||
salesforce.com Inc.(a) |
15,211 | 3,538,535 | ||||||
Silicon Laboratories Inc.(a) |
17,358 | 2,867,368 | ||||||
Snap Inc., Class A, NVS(a) |
75,553 | 2,458,495 | ||||||
Snowflake Inc., Class A(a) |
10,924 | 3,013,932 | ||||||
Splunk Inc.(a)(b) |
26,083 | 3,232,205 | ||||||
Sumo Logic Inc.(a) |
110,917 | 1,321,021 | ||||||
Teradata Corp.(a)(b) |
86,290 | 3,480,939 | ||||||
Texas Instruments Inc. |
16,266 | 2,919,584 | ||||||
Twitter Inc.(a) |
87,800 | 3,293,378 | ||||||
Velo3D Inc.(a)(b) |
405,488 | 2,615,398 | ||||||
Vicarious Surgical Inc., Class A, NVS(a)(b) |
328,654 |